Other
Common stock, shares issued (in shares)
Vertex Pharmaceuticals Common stock, shares issued (in shares) increased by 0.1% to 254.2M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.1%, from 257M to 254.2M. Over 5 years (FY 2020 to FY 2025), Common stock, shares issued (in shares) shows relatively stable performance with a -0.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2015
Last reportedQ1 2026May 5, 2026
How to read this metric
Increases indicate equity financing or stock-based compensation, while decreases result from share buybacks.
Detailed definition
This represents the total number of shares that the company has distributed to shareholders. It includes both shares cur...
Peer comparison
Used to calculate earnings per share and evaluate dilution trends compared to industry peers.
Metric ID:
other_common_stock_shares_issuedHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 259.1M | 256.2M | 254.5M | 255.6M | 256M | 256.6M | 257M | 257.5M | 257.8M | 257.8M | 257.7M | 258.3M | 258M | 257.7M | 256.9M | 257M | 256.3M | 254M | 254M | 254.2M |
| QoQ Change | — | -1.1% | -0.7% | +0.4% | +0.2% | +0.2% | +0.1% | +0.2% | +0.1% | +0.0% | -0.1% | +0.2% | -0.1% | -0.1% | -0.3% | +0.0% | -0.3% | -0.9% | +0.0% | +0.1% |
| YoY Change | — | — | — | — | -1.2% | +0.2% | +1.0% | +0.8% | +0.7% | +0.5% | +0.3% | +0.3% | +0.1% | -0.0% | -0.3% | -0.5% | -0.7% | -1.5% | -1.1% | -1.1% |
Range254M – 259.1M
CAGR-0.4%
Avg YoY Growth-0.2%
Median YoY Growth+0.0%
Current Streak2 quarters growth
Common stock, shares issued (in shares) at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's common stock, shares issued (in shares)?
- Vertex Pharmaceuticals (VRTX) reported common stock, shares issued (in shares) of 254.2M in Q1 2026.
- How has Vertex Pharmaceuticals's common stock, shares issued (in shares) changed year-over-year?
- Vertex Pharmaceuticals's common stock, shares issued (in shares) decreased by 1.1% year-over-year, from 257M to 254.2M.
- What is the long-term trend for Vertex Pharmaceuticals's common stock, shares issued (in shares)?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's common stock, shares issued (in shares) has grown at a -0.5% compound annual growth rate (CAGR), from 259.9M to 254M.
- What does common stock, shares issued (in shares) mean?
- The total number of shares the company has created and distributed to investors.